Belatacept and Sirolimus Prolong Nonhuman Primate Islet Allograft Survival: Adverse Consequences of Concomitant Alefacept Therapy

Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

(2011) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Late Cytomegalovirus Transmission and Impact of T-Depletion in Clinical Islet Transplantation

(2011) B. L. Gala-Lopez et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Effects of Acute Cytomegalovirus Infection on Rat Islet Allograft Survival

(2011) M. J. Smelt et al.   CELL TRANSPLANTATION

Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 Expression

(2010) D. J. Lo et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

(2010) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Experience with a Novel Efalizumab-Based Immunosuppressive Regimen to Facilitate Single Donor Islet Cell Transplantation

(2010) N. A. Turgeon et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Allo-HLA reactivity of virus-specific memory T cells is common

(2010) A. L. Amir et al.   BLOOD

LFA-1–specific therapy prolongs allograft survival in rhesus macaques

(2010) Idelberto R. Badell et al.   JOURNAL OF CLINICAL INVESTIGATION

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

(2010) Christian P. Larsen et al.   TRANSPLANTATION

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

(2009) Tim A Weaver et al.   NATURE MEDICINE

Islet Transplantation with Alemtuzumab Induction and Calcineurin-Free Maintenance Immunosuppression Results in Improved Short- and Long-Term Outcomes

(2008) Tatiana Froud et al.   TRANSPLANTATION